Hate of all kinds is hateful but this one is the worst

 The nude statue of President Trump was erected in Union Square according to the following link:

https://www.nydailynews.com/new-york/disturbing-statue-nude-donald-trump-pops-union-square-article-1.2756617

It is OK you don't like Ex-President Trump but to mock him like this shows the level to which people descend to make a political statement. I am not sure who the author of this abomination is, shame on you!

This is a textbook case of Hate.

“In time we hate that which we often fear.”

Breaking News: Novavax trials in India

 

Trump administration backed the NOVAVAX vaccine as one of the six vaccines in Operation Warp Speed. Operation Warp Speed provided $1.75B funding for this company. 

Novavax has matured and it is being tested in a trial in the US and Mexico with about 16,000 to 30,000 participants. Moderna and Pfizer vaccines have already been used in millions of vaccinations in the USA. The AstraZeneca vaccine has also been used in vaccinating millions in the UK and elsewhere. AstraZeneca vaccine manufactured by the Serum Institue in India has been shipped to many countries under a UN program.

Performance-wise, Novavax has 95.6% efficacy against the original strain, a reduced 85.6% against the UK variant but much less % efficiency (49.4%) against the South African variant.

https://www.ndtv.com/world-news/novavax-covid-vaccine-highly-effective-but-not-against-south-africa-variant-2359680

Serum Institute in India will be producing the Novavax vaccine.

The Novavax as well as the Nasally delivered Bharath Biotech's weakened virus has approval for clinical testing.

https://www.business-standard.com/article/current-affairs/more-covid-19-vaccine-candidates-get-approval-for-clinical-trials-in-india-121020502044_1.html

Watch this Video:

Problems using the STOCK data type in MS EXCEL

  Microsoft introduced the Stock datatype previously. It does work with a few minor points of irritation. Still, I recommend this program for retail, individual investors with the usual warning that you do so at your own risk.

The problems I have noticed are the following:

1. New IPOs take considerable time to appear, sometimes weeks

2. Suddenly you start seeing the message that some of the items could not be updated, etc.

3. Recently, the Excel program is getting sluggish (not all the time but enough to cause discomfort) and the controls for FILE, Data, View, etc. get slowed down to the extent, you rapidly lose heart and interest.

4. Sometimes the stock data type does not get updated even after using the 'Refresh' control. Only one submenu item gets enabled in the 'Refresh, button.

5. Interestingly if you create a new instance of the stock in a different cell, it gets updated.

The program should work without these hitches if it has to be taken seriously.

This is the version of Office365/Excel I am using on Windows 10 (x64) with the most current update:




Here are some pictures of misbehaving Excel sheets:

Obviously, the feedback has been sent a couple of times.


Here are some links if you are not familiar with the STOCK data type in Excel.

How do you use the stock data type in MS Excel?

https://hodentekhelp.blogspot.com/2020/05/how-do-you-use-stock-data-type-in-ms.html


Does Stock Analysis with Microsoft Excel Work?

https://hodentekhelp.blogspot.com/2016/03/does-stock-analysis-with-microsoft.html


How do you extract financial data from the web using MS Excel?

https://hodentekhelp.blogspot.com/2020/06/how-do-you-extract-financial-data-from.html


How do you create a moving average using MS Excel?

https://hodentekhelp.blogspot.com/2017/10/how-do-you-create-moving-average-using.html




Good luck!

Nasal COVID-19 vaccine goes Phase 1 trial in Hyderabad

Bharath Biotech has launched Phase-I trial (10 volunteers) of its intranasal vaccine BBV154 in Hyderabad,  India. More trials are planned in Chennai, Nagpur and Patna.

A collage of noses from BING

https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/bharat-biotech-nasal-covid19-vaccine-phase-1-trials-hyderabad-1777780-2021-03-10


More here (March 12, 2021):

https://www.firstpost.com/tech/science/bharat-biotechs-intranasal-vaccine-for-covid-19-everything-we-know-so-far-about-bbv154-9408701.html


In addition to Bharath Biotech in India, three other companies/institutionss have been working on a nasal delviery system for the COVID_19 vaccine. They are,

The US company Altimmune is developing a nasal spary called AdCovid - 180 Volunteers

The company in UK, Codagenix is devleoping a nasal spray COVI-VAC in colloboration with the Serum Insitute in India--48 volunteers

China is working on its nasal vaccine, a colloboration betweeen Beijing Wantai Biological, Xiamen University and Hong Kong University-100 volunteers

Tracking COVID-19 vaccinations

Follow these vaccine trackers to get a feel for what is happening with vaccinations globally:

The London School of Hygiene & Tropical Medicine Vaccine Tracker is updated weekly and shows the current stage of each development.

https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/

WHO Vaccine Tracker – The WHO is tracking the COVID-19 candidate vaccines that are under development.

https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Milken Institute Vaccine Tracker – The Milken Institute publishes, and regularly updates a tracker of possible treatments and vaccines for COVID-19 that scientists are currently working on.

https://www.covid-19vaccinetracker.org/

New York Times – The NYT tracker includes brief summaries of each development.

https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html

This above is from the source: 

https://ourworldindata.org/covid-vaccinations

Here is the link to European vaccine tracker:

https://qap.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab